Increased toxicity by transforming growth factor-beta 1 in liver cells overexpressing CYP2E1

Free Radical Biology and Medicine

Volumn 41, Issue 7, 2006, Pages 1100-1112

  Zhuge, Jian ^a   Cederbaum, Arthur I ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; CYP2E1; HepG2 cells; Mitochondrial membrane potential; Rat hepatocytes; Reactive oxygen species; Reduced glutathione; TGF 1

Indexed keywords

ALCOHOL; ANTIOXIDANT; CYTOCHROME P450 2E1; GLUTATHIONE; PYRAZOLE; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA1; TRIFLUOPERAZINE;

ALCOHOL LIVER DISEASE; ARTICLE; CELL STRAIN HEPG2; CELL VIABILITY; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; LIVER TOXICITY; MEMBRANE DAMAGE; MEMBRANE PERMEABILITY; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL MEMBRANE POTENTIAL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIOXIDANTS; CELL DEATH; CELL SURVIVAL; CYTOCHROME P-450 CYP2E1; GENE EXPRESSION; GLUTATHIONE; HEPATOCYTES; HUMANS; RATS; REACTIVE OXYGEN SPECIES; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 33748310762     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2006.06.017     Document Type: Article

References (42)

1. Ramaiah S., Rivera C., and Arteel G. Early-phase alcoholic liver disease: an update on animal models, pathology, and pathogenesis. Int. J. Toxicol. 23 (2004) 217-231
2. Schuster N., and Krieglstein K. Mechanisms of TGF-beta-mediated apoptosis. Cell Tissue Res. 307 (2002) 1-14
3. Elliott R.L., and Blobe G.C. Role of transforming growth factor beta in human cancer. J. Clin. Oncol. 23 (2005) 2078-2093
4. Neuman M.G. Apoptosis in diseases of the liver. Crit. Rev. Clin. Lab. Sci. 38 (2001) 109-166
5. Kamimura S., and Tsukamoto H. Cytokine gene expression by Kupffer cells in experimental alcoholic liver disease. Hepatology 22 (1995) 1304-1309
6. Sanchez A., Alvarez A.M., Benito M., and Fabregat I. Apoptosis induced by transforming growth factor-beta in fetal hepatocyte primary cultures: involvement of reactive oxygen intermediates. J. Biol. Chem. 271 (1996) 7416-7422
7. Herrera B., Alvarez A.M., Sanchez A., Fernandez M., Roncero C., Benito M., and Fabregat I. Reactive oxygen species (ROS) mediates the mitochondrial-dependent apoptosis induced by transforming growth factor (beta) in fetal hepatocytes. FASEB J. 15 (2001) 741-751
8. Herrera B., Murillo M.M., Alvarez-Barrientos A., Beltran J., Fernandez M., and Fabregat I. Source of early reactive oxygen species in the apoptosis induced by transforming growth factor-beta in fetal rat hepatocytes. Free Radic. Biol. Med. 36 (2004) 16-26
9. Albright C.D., Salganik R.I., Craciunescu C.N., Mar M.H., and Zeisel S.H. Mitochondrial and microsomal derived reactive oxygen species mediate apoptosis induced by transforming growth factor-beta1 in immortalized rat hepatocytes. J. Cell. Biochem. 89 (2003) 254-261
10. Kayanoki Y., Fujii J., Suzuki K., Kawata S., Matsuzawa Y., and Taniguchi N. Suppression of antioxidative enzyme expression by transforming growth factor-beta 1 in rat hepatocytes. J. Biol. Chem. 269 (1994) 15488-15492
11. Rodrigues C.M., Ma X., Linehan-Stieers C., Fan G., Kren B.T., and Steer C.J. Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation. Cell Death Differ. 6 (1999) 842-854
12. Diez-Fernandez C., Andres D., and Cascales M. Attenuating effects of heat shock against TGF-beta1-induced apoptosis in cultured rat hepatocytes. Free Radic. Biol. Med. 33 (2002) 835-846
13. Gonzalez F.J. Role of cytochromes P450 in chemical toxicity and oxidative stress: studies with CYP2E1. Mutat. Res. 569 (2005) 101-110
14. Tsutsumi M., Lasker J.M., Shimizu M., Rosman A.S., and Lieber C.S. The intralobular distribution of ethanol-inducible P450IIE1 in rat and human liver. Hepatology 10 (1989) 437-446
15. Buhler R., Lindros K.O., Nordling A., Johansson I., and Ingelman-Sundberg M. Zonation of cytochrome P450 isozyme expression and induction in rat liver. Eur. J. Biochem. 204 (1992) 407-412
16. Ingelman-Sundberg M., Johansson I., Penttila K.E., Glaumann H., and Lindros K.O. Centrilobular expression of ethanol-inducible cytochrome P-450 (IIE1) in rat liver. Biochem. Biophys. Res. Commun. 157 (1988) 55-60
17. French S.W., Nash J., Shitabata P., Kachi K., Hara C., Chedid A., and Mendenhall C.L. Pathology of alcoholic liver disease. VA Cooperative Study Group 119. Semin. Liver Dis. 13 (1993) 154-169
18. Van Waes L., and Lieber C.S. Early perivenular sclerosis in alcoholic fatty liver: an index of progressive liver injury. Gastroenterology 73 (1977) 646-650
19. Fang C., Lindros K.O., Badger T.M., Ronis M.J., and Ingelman-Sundberg M. Zonated expression of cytokines in rat liver: effect of chronic ethanol and the cytochrome P450 2E1 inhibitor, chlormethiazole. Hepatology 27 (1998) 1304-1310
20. Chen Q., and Cederbaum A.I. Cytotoxicity and apoptosis produced by cytochrome P450 2E1 in Hep G2 cells. Mol. Pharmacol. 53 (1998) 638-648
21. Caro A.A., and Cederbaum A.I. Oxidative stress, toxicology, and pharmacology of CYP2E1. Annu. Rev. Pharmacol. Toxicol. 44 (2004) 27-42
22. Fukuda K., Kawata S., Tamura S., Matsuda Y., Inui Y., Igura T., Inoue S., Kudara T., and Matsuzawa Y. Altered regulation of Src tyrosine kinase by transforming growth factor beta1 in a human hepatoma cell line. Hepatology 28 (1998) 796-804
23. Buenemann C.L., Willy C., Buchmann A., Schmiechen A., and Schwarz M. Transforming growth factor-beta1-induced Smad signaling, cell-cycle arrest and apoptosis in hepatoma cells. Carcinogenesis 22 (2001) 447-452
24. Gressner A.M., Lahme B., Mannherz H.G., and Polzar B. TGF-beta-mediated hepatocellular apoptosis by rat and human hepatoma cells and primary rat hepatocytes. J. Hepatol. 26 (1997) 1079-1092
25. Huang Y.L., and Chou C.K. Bcl-2 blocks apoptotic signal of transforming growth factor-beta in human hepatoma cells. J. Biomed. Sci. 5 (1998) 185-191
26. Park S.S., Eom Y.W., Kim E.H., Lee J.H., Min do S., Kim S., Kim S.J., and Choi K.S. Involvement of c-Src kinase in the regulation of TGF-beta1-induced apoptosis. Oncogene 23 (2004) 6272-6281
27. Wu D., and Cederbaum A.I. Role of p38 MAPK in CYP2E1-dependent arachidonic acid toxicity. J. Biol. Chem. 278 (2003) 1115-1124
28. Zhuge J., and Cederbaum A.I. Serum deprivation-induced HepG2 cell death is potentiated by CYP2E1. Free Radic. Biol. Med. 40 (2006) 63-74
29. Mitsui H., Takuwa N., Maruyama T., Maekawa H., Hirayama M., Sawatari T., Hashimoto N., Takuwa Y., and Kimura S. The MEK1-ERK map kinase pathway and the PI 3-kinase-Akt pathway independently mediate anti-apoptotic signals in HepG2 liver cancer cells. Int. J. Cancer 92 (2001) 55-62
30. Darzynkiewicz Z., and Juan G. DNA content measurement for DNA ploidy and cell cycle analysis. In: Robinson J.P. (Ed). Current protocols in cytometry (1997), Wiley, Hoboken, NJ 7.5.1-7.5.24
31. Ghosal A., Hapangama N., Yuan Y., Lu X., Horne D., Patrick J.E., and Zbaida S. Rapid determination of enzyme activities of recombinant human cytochromes P450, human liver microsomes and hepatocytes. Biopharm. Drug Dispos. 24 (2003) 375-384
32. Caro A.A., and Cederbaum A.I. Inhibition of CYP2E1 catalytic activity in vitro by S-adenosyl-l-methionine. Biochem. Pharmacol. 69 (2005) 1081-1093
33. Bai J., Rodriguez A.M., Melendez J.A., and Cederbaum A.I. Overexpression of catalase in cytosolic or mitochondrial compartment protects HepG2 cells against oxidative injury. J. Biol. Chem. 274 (1999) 26217-26224
34. Vanden Hoek T.L., Li C., Shao Z., Schumacker P.T., and Becker L.B. Significant levels of oxidants are generated by isolated cardiomyocytes during ischemia prior to reperfusion. J. Mol. Cell. Cardiol. 29 (1997) 2571-2583
35. Herzer K., Ganten T.M., Schulze-Bergkamen H., Grosse-Wilde A., Koschny R., Krammer P.H., and Walczak H. Transforming growth factor beta can mediate apoptosis via the expression of TRAIL in human hepatoma cells. Hepatology 42 (2005) 183-192
36. Broekemeier K.M., Dempsey M.E., and Pfeiffer D.R. Cyclosporin A is a potent inhibitor of the inner membrane permeability transition in liver mitochondria. J. Biol. Chem. 264 (1989) 7826-7830
37. Perez M.J., and Cederbaum A.I. Antioxidant and pro-oxidant effects of a manganese porphyrin complex against CYP2E1-dependent toxicity. Free Radic. Biol. Med. 33 (2002) 111-127
38. Brady J.F., Ishizaki H., Fukuto J.M., Lin M.C., Fadel A., Gapac J.M., and Yang C.S. Inhibition of cytochrome P-450 2E1 by diallyl sulfide and its metabolites. Chem. Res. Toxicol. 4 (1991) 642-647
39. Curtin J.F., Donovan M., and Cotter T.G. Regulation and measurement of oxidative stress in apoptosis. J. Immunol. Methods 265 (2002) 49-72
40. Yoon Y.S., Lee J.H., Hwang S.C., Choi K.S., and Yoon G. TGF beta1 induces prolonged mitochondrial ROS generation through decreased complex IV activity with senescent arrest in Mv1Lu cells. Oncogene 24 (2005) 1895-1903
41. Ribeiro A., Bronk S.F., Roberts P.J., Urrutia R., and Gores G.J. The transforming growth factor beta(1)-inducible transcription factor TIEG1, mediates apoptosis through oxidative stress. Hepatology 30 (1999) 1490-1497
42. Franklin C.C., Rosenfeld-Franklin M.E., White C., Kavanagh T.J., and Fausto N. TGFbeta1-induced suppression of glutathione antioxidant defenses in hepatocytes: caspase-dependent post-translational and caspase-independent transcriptional regulatory mechanisms. FASEB J. 17 (2003) 1535-1537